Guest
戻る
小林製薬(中国)有限公司
Foreign investment and related service provision
Research and development of new products and high‑technology
Business and investment consulting
Outsourcing services for parent and affiliated companies
Wholesale, online retail, import‑export of daily necessities, food, cosmetics, medical devices (excl
Mechanical equipment leasing
Business information consulting
Corporate management consulting
Marketing planning
Conference and event services
Technology development, consulting, service and transfer in pharmaceutical, biotechnology, and IT se
Import‑export of goods and technology
Pharmaceutical, medical device, daily goods, and food manufacturing and sales
China
180 人
180 人
会社名
Group 親会社 子会社 得意先 仕入先 銀行等 株主等
江苏小林制药有限公司
グループ会社 親会社 子会社 得意先 仕入先 銀行・融資・与信 出資・持分・株主
小林集团
グループ会社 親会社 子会社 得意先 仕入先 銀行・融資・与信 出資・持分・株主
小林制薬株式会社
グループ会社 親会社 子会社 得意先 仕入先 銀行・融資・与信 出資・持分・株主
小林制药株式会社
グループ会社 親会社 子会社 得意先 仕入先 銀行・融資・与信 出資・持分・株主

https://www.kobayashi-cn.com/747#:~:text=%E5%B0%8F%E6%9E%97%E5%88%B6%E8%8D%AF%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E6%98%AF%E4%B8%80%E5%AE%B6%E5%85%B7%E6%9C%89130%E5%A4%9A%E5%B9%B4%E5%8E%86%E5%8F%B2%E7%9A%84%EF%BC%8C%E4%BB%A5%E4%BA%A7%E5%93%81%E5%BC%80%E5%8F%91%E4%B8%BA%E4%B8%BB%E7%9A%84%E4%BC%81%E4%B8%9A%EF%BC%8C%E4%B8%BB%E8%A6%81%E4%BB%8E%E4%BA%8B%E8%8D%AF%E5%93%81%EF%BC%8C%E5%8C%BB%E7%96%97%E5%99%A8%E6%A2%B0%EF%BC%8C%E6%97%A5%E7%94%A8%E5%93%81%EF%BC%8C%E9%A3%9F%E5%93%81%E7%AD%89%E7%9A%84%E7%A0%94%E5%8F%91%E7%94%9F%E4%BA%A7%E4%B8%8E%E9%94%80%E5%94%AE%E3%80%82,%E4%BA%A7%E5%93%81%E4%B8%8D%E4%BB%85%E5%9C%A8%E6%97%A5%E6%9C%AC%E5%9B%BD%E5%86%85%E9%94%80%E5%94%AE%EF%BC%8C%E8%BF%98%E9%94%80%E5%BE%80%E7%BE%8E%E5%9B%BD%EF%BC%8C%E8%8B%B1%E5%9B%BD%EF%BC%8C%E4%B8%9C%E5%8D%97%E4%BA%9A%E7%AD%89%E4%B8%96%E7%95%8C%E5%90%84%E5%9C%B0%E3%80%82%20%E6%9C%AC%E5%85%AC%E5%8F%B8%E6%88%90%E7%AB%8B%E4%BA%8E2018%E5%B9%B4%EF%BC%8C%E6%88%90%E7%AB%8B%E8%87%B3%E4%BB%8A%E5%9C%A8%E5%90%91%E5%B9%BF%E5%A4%A7%E4%B8%AD%E5%9B%BD%E6%B6%88%E8%B4%B9%E8%80%85%E6%8F%90%E4%BE%9B%E9%AB%98%E5%93%81%E8%B4%A8%E3%80%81%E9%AB%98%E9%99%84%E5%8A%A0%E5%80%BC%E7%9A%84%E4%BA%A7%E5%93%81%E7%9A%84%E5%90%8C%E6%97%B6%EF%BC%8C%E4%B9%9F%E4%BD%9C%E4%B8%BA%E5%B0%8F%E6%9E%97%E9%9B%86%E5%9B%A2%E5%86%85%E9%87%8D%E8%A6%81%E7%9A%84%E6%8A%95%E8%B5%84%E3%80%81%E7%A0%94%E5%8F%91%E3%80%81%E9%94%80%E5%94%AE%E5%9F%BA%E5%9C%B0%EF%BC%8C%E6%88%90%E4%B8%BA%E9%9B%86%E5%9B%A2%E5%86%85%E4%B8%8D%E5%8F%AF%E6%88%96%E7%BC%BA%E7%9A%84%E9%87%8D%E8%A6%81%E7%BB%84%E6%88%90%E3%80%82
2026-03-30 11:33 (Model: gpt-oss:20b )